Iasella, M.P.; Ruttens, D.; Hompes, D.; Vandecaveye, V.; Sciot, R.; Deroose, C.; Douchy, T.; Decramer, T.; Jacobs, S.; Denayer, E.;
et al. Reply to Taal et al. Comment on “Iasella et al. Close Follow-Up of Patients with Neurofibromatosis Type 1 Reduces the Incidence of Malignant Peripheral Nerve Sheath Tumour. Cancers 2025, 17, 1306”. Cancers 2025, 17, 3356.
https://doi.org/10.3390/cancers17203356
AMA Style
Iasella MP, Ruttens D, Hompes D, Vandecaveye V, Sciot R, Deroose C, Douchy T, Decramer T, Jacobs S, Denayer E,
et al. Reply to Taal et al. Comment on “Iasella et al. Close Follow-Up of Patients with Neurofibromatosis Type 1 Reduces the Incidence of Malignant Peripheral Nerve Sheath Tumour. Cancers 2025, 17, 1306”. Cancers. 2025; 17(20):3356.
https://doi.org/10.3390/cancers17203356
Chicago/Turabian Style
Iasella, Maria Pia, Dries Ruttens, Daphne Hompes, Vincent Vandecaveye, Raf Sciot, Christophe Deroose, Thomas Douchy, Thomas Decramer, Sandra Jacobs, Ellen Denayer,
and et al. 2025. "Reply to Taal et al. Comment on “Iasella et al. Close Follow-Up of Patients with Neurofibromatosis Type 1 Reduces the Incidence of Malignant Peripheral Nerve Sheath Tumour. Cancers 2025, 17, 1306”" Cancers 17, no. 20: 3356.
https://doi.org/10.3390/cancers17203356
APA Style
Iasella, M. P., Ruttens, D., Hompes, D., Vandecaveye, V., Sciot, R., Deroose, C., Douchy, T., Decramer, T., Jacobs, S., Denayer, E., Van Calenbergh, F., Legius, E., & Brems, H.
(2025). Reply to Taal et al. Comment on “Iasella et al. Close Follow-Up of Patients with Neurofibromatosis Type 1 Reduces the Incidence of Malignant Peripheral Nerve Sheath Tumour. Cancers 2025, 17, 1306”. Cancers, 17(20), 3356.
https://doi.org/10.3390/cancers17203356
